80 related articles for article (PubMed ID: 19282207)
21. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
Henney HR; Fitzpatrick A; Stewart J; Runyan JD
Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid and blood concentrations of toltrazuril 5% suspension in the horse after oral dosing.
Furr M; Kennedy T
Vet Ther; 2000; 1(2):125-32. PubMed ID: 19757559
[TBL] [Abstract][Full Text] [Related]
23. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
Dowse R; Scherzinger SS; Kanfer I
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
[TBL] [Abstract][Full Text] [Related]
26. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
[TBL] [Abstract][Full Text] [Related]
28. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
Segev G; Westropp JL; Kulik C; Lavy E
Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of cimetidine in dogs after oral administration of cimetidine tablets.
Le Traon G; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2009 Jun; 32(3):213-8. PubMed ID: 19646084
[TBL] [Abstract][Full Text] [Related]
30. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
32. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs.
Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG
J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284
[TBL] [Abstract][Full Text] [Related]
35. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
[TBL] [Abstract][Full Text] [Related]
37. Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin.
Witte DG; Brune ME; Katwala SP; Milicic I; Kerwin JF; Hancock AA
J Pharmacol Exp Ther; 1997 Aug; 282(2):891-8. PubMed ID: 9262356
[TBL] [Abstract][Full Text] [Related]
38. In-vivo pharmacokinetic characteristics of a transdermal phenylpropanolamine (PPA) preparation.
Devane J; Mulligan S; Foynes M; Martin M
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():297-9. PubMed ID: 1820895
[TBL] [Abstract][Full Text] [Related]
39. Bioavailability and cardiovascular safety of Dexatrim (phenylpropanolamine hydrochloride) from a controlled-release caplet.
Shargel L; Silverman HI; Cohen P; Brisson J; Dennis S
Biopharm Drug Dispos; 1990 Oct; 11(7):569-83. PubMed ID: 2265237
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of phenylpropanolamine in the treatment of urethral sphincter mechanism incompetence in the bitch.
Scott L; Leddy M; Bernay F; Davot JL
J Small Anim Pract; 2002 Nov; 43(11):493-6. PubMed ID: 12463265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]